Anonymousabout 3 hours ago
A 2026 study published in Nature Communications found that a single 25 mg dose of psilocybin produced measurable structural and functional brain changes persisting at least one month in 28 healthy volunteers, adding to a growing body of evidence linking psychedelics to neuroplasticity. While the findings arrive amid an unprecedented FDA fast-track push and billions in projected market value for psychedelic therapeutics, critical questions remain about sample size, replication, clinical significance, and safety for vulnerable populations.